Skip to Content

5-Years Data: High-Dose Thoracic Radiotherapy Increases OS Significantly for Patients with Limited Stage of Small-Cell Lung Cancer

Compared with low-dose thoracic radiotherapy, a high dose twice daily can increase overall survival (OS) from 22.6 months to 43.6 months. In this MEDtalk, Bjørn Henning Grønberg, NTNU, Trondheim, Norway, presents interesting data from the study.

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top